Trump Administration Betrays Pro-Life Promises by Failing to Regulate Dangerous Abortion Drug Mifepristone
Source: Jordan Boyd. "Trump Admin Claimed To Be Pro-Life, But Won't Regulate Mifepristone." February 24, 2026. thefederalist.com
The Gist
The author argues that Trump promised to be pro-life but is breaking that promise by refusing to crack down on a dangerous abortion pill. Women are getting hurt, states can't enforce their laws, and pro-life voters are getting fed up with empty promises.
Conclusion
The Trump administration is failing to fulfill its pro-life promises by refusing to regulate mifepristone, thereby endangering women and undermining states' abortion laws
Premises
- Mifepristone is demonstrably dangerous to women, with studies showing serious adverse events occur in more than 1 in 10 women who take it
- The Trump administration promised to review and regulate mifepristone but has taken no meaningful action despite being in office for over a year
- The FDA is deliberately stalling by claiming to conduct a safety study while not actually reviewing any data
- Biden-era mail-order abortion expansions allow dangerous unsupervised use of mifepristone and undermine state abortion laws
- Pro-life voters (32% of Republicans) are threatening to abandon the party if leaders weaken pro-life policies
- States cannot effectively enforce their abortion laws because federal mail-order schemes circumvent state sovereignty
- The FDA could immediately reinstate Trump's first-term safety protocols without waiting for any study
Assumptions
- The Trump administration has a moral and political obligation to fulfill its pro-life campaign promises
- Federal drug regulation should prioritize protecting women from medical harm over access considerations
- State sovereignty in regulating abortion should be respected and protected by federal policy
- Pro-life voters' political support is contingent on concrete policy actions, not just rhetoric
- Medical studies showing adverse effects of mifepristone are reliable and should drive policy decisions